August 9th 2012
£1010 / $1565 / €1205
A changing industry landscape
Mergers and acquisitions have always played a key role in the advanced wound care industry and have enabled the market leaders to expand their technology to address new sections of the market and provide access to new technologies. But things are hotting up. Smith & Nephew continues to add to its portfolio with the acquisition in May 2012 of Kalypto Medical while pharmaceutical companies flex their financial muscle: Shire purchased BioHealing in June 2011 while Sanofi’s purchase of Genzyme in April 2011 has introduced the new Sanofi Biosurgery division.
Private equity gets more involved
The headline acquisition of the NPWT leading company KCI by the APAX consortium is just the latest of a string of private equity transactions. Nordic Capital and Avista Capital Partners purchased ConvaTec in August 2008, Systagenix was formed in December 2008 through One Equity Partners' purchase of Ethicon Professional Wound Care, and Investor AB took full control of Mölnlycke in late 2010.
Biologics: the growth sector of the future?
With price pressures in the NPWT sector and low prices driven by high competition in the Moist Dressings sector, the spotlight has been thrown on Biologics. While all sectors are expected to return to stronger annual growth, only the biologics sector is expected to maintain double digit growth from 2015 onwards as products currently in development are launched.
Key statistics and forecasts provide a real insight to the future of this critical device sector
About the Author
This report has been researched and written by senior Espicom medical market analyst Joanne Maddox. For over 10 years she has played a pivotal role in tracking trends in medical device and equipment markets and companies. A former editor of Medical Device Companies Analysis she has also written: